![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Small Increase in Dolutegravir Trough, but
Equivalent Total Exposure with Simeprevir
|
|
|
Reported by Jules Levin
International Workshop on Clinical Pharmacology of Antiviral Therapy. June 14-16, 2017, Chicago, IL
Christine E. MacBrayne1, Jose Castillo-Mancilla2, James R. Burton2, Samantha MaWhinney3, Charlotte B. Wagner1, Kestutis Micke1, Jordan Fey1, Ryan T. Huntley1, Bayli Larson1, Lane R. Bushman1, Jennifer J. Kiser1
University of Colorado 1Skaggs School of Pharmacy and Pharmaceutical Sciences, 2School of Medicine, 3School of Public Health
![EASL1](../images/072217/072217-7/EASL1.gif)
![EASL2](../images/072217/072217-7/EASL2.gif)
![EASL3](../images/072217/072217-7/EASL3.gif)
![EASL4](../images/072217/072217-7/EASL4.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|